Home/Pipeline/Umbilical cord stem cells for severe COVID

Umbilical cord stem cells for severe COVID

Severe COVID-19 infection

Research/PreclinicalActive

Key Facts

Indication
Severe COVID-19 infection
Phase
Research/Preclinical
Status
Active
Company

About SaxoCell

SaxoCell is a privately held, non-profit consortium founded in 2001 and based in Dresden, Germany. It operates as a regional innovation cluster uniting academic, clinical, and industrial partners to advance the field of cell and gene therapy. Its core mission is to develop more affordable and accessible allogeneic (off-the-shelf) cell therapeutics through research projects focused on novel applications, production methods, and automation. The cluster is pre-revenue, acting as a collaborative R&D and technology transfer engine rather than a single commercial biotech entity.

View full company profile